Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1066 participants.

Also called NCT06901960

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,066 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06901960
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06901960. Randomized; no masking; primary purpose prevention. Start 2025-04-02 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
Acronym
POCKET
Condition
Chronic Kidney Disease (Stages 3b-5)
Intervention (Device)
A mobile artificial intelligence-enhanced electrocardiogram device estimating plasma potassium categories (<5 mmol/L, 5 - <5.5 mmol/L, 5.5 - <6.0 mmol/L and ≥ 6.0 mmol/L)
Lead sponsor
Peking University First Hospital (class: other)

Record details

Record id
cardio:ct-nct06901960
Content hash
cae9787b5256b0f64193476a2d3dbfd903e64a1a7510d9568aad7165381cfe16